SCHEMBL18948464

SCHEMBL18948464

BC(=O)/C=C/[C@H]1CCC(=O)N1I

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 2/20 0.31
▸ PTGER2 P43116 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092706 0.79 PTGER4 (0.35) PTGER4PTGER2
SCHEMBL18948465 0.75 PTGER4 (0.34) PTGER4PTGER2
SCHEMBL18832640 0.71 — —
SCHEMBL18832507 0.71 — —
SCHEMBL22025479 0.69 PTGER4 (0.31) PTGER4PTGER2
SCHEMBL18827395 0.62 — —
SCHEMBL23211224 0.62 ACE (0.44) —
SCHEMBL18832362 0.62 ACE (0.44) —
SCHEMBL18832608 0.60 — —
SCHEMBL18832370 0.58 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676712-B2 Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions CAYMAN CHEMICAL COMPANY, INC. (US) 2017-06-13 — — US disclosed
Send feedback